Exagen Inc. SEC filings XGN

Exagen Inc. has 421 filings in SEC EDGAR's recent list, going back to Dec 29, 2003. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 4, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders Apr 27, 2026 Dec 31, 2025
10-K Annual report Mar 10, 2026 Dec 31, 2025
ARS Annual report to shareholders Apr 30, 2025 Dec 31, 2024
10-K Annual report Mar 11, 2025 Dec 31, 2024
ARS Annual report to shareholders Apr 26, 2024 Dec 31, 2023
10-K Annual report Mar 18, 2024 Dec 31, 2023
ARS Annual report to shareholders Apr 28, 2023 Dec 31, 2022
10-K Annual report Mar 20, 2023 Dec 31, 2022
10-K Annual report Mar 22, 2022 Dec 31, 2021
10-K/A Amended annual report Apr 1, 2021 Dec 31, 2020
10-K Annual report Mar 16, 2021 Dec 31, 2020
10-K Annual report Mar 25, 2020 Dec 31, 2019

Showing 12 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
XGN (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Vista, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1274737
Former names
EXAGEN DIAGNOSTICS INC (until May 18, 2017)

Other Services-Medical Laboratories companies

All 29 Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.